{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-104002","form_type":"8-K","ticker":"ANVS","cik":"0001477845","company_name":"Annovis Bio, Inc.","filed_at":"2024-09-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.198212+00:00","generated_at":"2026-05-31T00:42:53.899836+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"medium","headline":"Annovis files three new patents for Buntanetap combinations with Trulicity and Viagra","bullets":["Patents cover Buntanetap + Trulicity (GLP-1), Buntanetap + Viagra (PDE5i), and triple combo.","Preclinical synergy data showed cognition in AD mouse models improved beyond healthy controls.","Combinations positioned for Phase 3 trials; Buntanetap completed Phase 3; Trulicity and Viagra are FDA-approved.","CEO: combination could restore and improve cognition, offering new hope in dementia fight.","Annovis expands IP portfolio for neurodegenerative disorders with these filings."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-104002","json":"https://secwatch.observer/filing/0001104659-24-104002.json","markdown":"https://secwatch.observer/filing/0001104659-24-104002.md","text":"https://secwatch.observer/filing/0001104659-24-104002.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1477845/000110465924104002/0001104659-24-104002-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1477845/000110465924104002/tm2425199d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T00:42:53.899836+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}